Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Xiang-Dong Shen"'
Autor:
Si‐Man Huang, Tao Tao, Chao‐Ling Wan, Tian‐Mei Wu, Han‐Yu Cao, Yan Qiu, Xiang‐Dong Shen, Bin‐Ru Wang, Shuai‐Shuai Ge, Yan‐Yan Li, Tong‐Tong Zhang, Bing Wu, Sheng‐Li Xue
Publikováno v:
Clinical Case Reports, Vol 11, Iss 1, Pp n/a-n/a (2023)
Abstract Philadelphia chromosome‐positive acute myeloid leukemia (Ph + AML) is a rare type of AML with a low survival rate and poor prognosis. We first report a Ph + AML patient who remained in long‐term remission after the combination of flumati
Externí odkaz:
https://doaj.org/article/ed773244ff8842be89b88a44e8235d72
Autor:
Zheng Li, Jun Wang, Shuai-Shuai Ge, Qiao-Cheng Qiu, Jia-Hui Du, Shuang-Shuang Shan, Xiang-Dong Shen, Chao-Ling Wan, Bin-Ru Wang, De-Pei Wu, Hui-Ying Qiu, Sheng-Li Xue
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Acute myeloid leukemia (AML) with t(8;21) is categorized as favorable-risk AML, but KIT mutations show a significantly poor prognostic impact in such patients. Persistent vulnerability to relapse is a major challenge in the treatment of this subtype
Externí odkaz:
https://doaj.org/article/f633782528a04437a06d580daaa1350b
Autor:
Han‐Yu Cao, Tao Tao, Xiang‐Dong Shen, Lian Bai, Chao‐Ling Wan, De‐Pei Wu, Jin‐Li Li, Sheng‐Li Xue
Publikováno v:
Clinical Case Reports, Vol 10, Iss 2, Pp n/a-n/a (2022)
Abstract There have been few reports on the treatment of central nervous system (CNS) acute myeloid leukemia (AML) relapse. This case study demonstrates that bevacizumab may be a viable treatment option when combined with IT chemotherapy as maintenan
Externí odkaz:
https://doaj.org/article/eb46f7faed6b40beb26682c618ddcd92
Autor:
Bin-Ru Wang, Chao-Ling Wan, Song-Bai Liu, Qiao-Cheng Qiu, Tian-Mei Wu, Jun Wang, Yan-Yan Li, Shuai-Shuai Ge, Yan Qiu, Xiang-Dong Shen, Sheng-Li Xue, Zheng Li
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
The management of patients with relapsed or refractory (R/R) acute myeloid leukaemia (AML) remains a challenge with few reliably effective treatments. Chidamide, a new selective HDAC inhibitor, has demonstrated some effectiveness in AML patients. Her
Externí odkaz:
https://doaj.org/article/666477bf1ffb45baa59227e8b10908f1
Publikováno v:
Water Science and Engineering, Vol 5, Iss 3, Pp 269-277 (2012)
The unique regional climate characteristics are among the main reasons for the frequent wind-sand activity in arid and cold areas in the agro-pastoral ecotone in Inner Mongolia, China. This paper focuses on the time series of temperature and precipit
Externí odkaz:
https://doaj.org/article/81a917673c5d42b0840f1eab7f9714f0
Autor:
Shuai‐Shuai Ge, Qiao‐Cheng Qiu, Hai‐Ping Dai, Xiang‐Dong Shen, Tian‐Mei Wu, Jia‐Hui Du, Chao‐Ling Wan, Hong‐Jie Shen, De‐Pei Wu, Sheng‐Li Xue, Song‐Bai Liu
Publikováno v:
British Journal of Haematology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c59da9b62ba7af2134619cc695c620e6
https://doi.org/10.1111/bjh.18877
https://doi.org/10.1111/bjh.18877
Autor:
Man Qiao, Chao-Ling Wan, Shengli Xue, Jing-Ying Zou, Xiang-Dong Shen, Song-Bai Liu, Qiao-cheng Qiu, Jia Yin
Publikováno v:
Leukemia & Lymphoma. 62:3300-3303
T-cell acute lymphoblastic leukemia (T-ALL) is a heterogeneous hematologic disease characterized by immature lymphoid cell proliferation in the bone marrow, peripheral blood and other organs [1]. C...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e460e4c351a811df1ab4f047f27c18a
https://doi.org/10.1080/10428194.2021.1957876
https://doi.org/10.1080/10428194.2021.1957876
Autor:
Xiang-Dong Shen, Xu-Dong Pan, Sen-Sen Shi, Ting Xu, Sheng-Li Xue, Jun Wang, Chao-Ling Wan, Yu-Ting Yao, Wei Lei, Tao Tao
Publikováno v:
Medicine. 102:e33399
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46af0d18dcb4a7e67c37b7dd1d056c97
https://doi.org/10.1097/md.0000000000033399
https://doi.org/10.1097/md.0000000000033399
Publikováno v:
Journal of Korea Trade. 24:87-105
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b923feef7ac520fc4d5e100ae2a6fa7
https://doi.org/10.35611/jkt.2020.24.5.87
https://doi.org/10.35611/jkt.2020.24.5.87
Autor:
Hanyu Cao, Tao Tao, Xiang-Dong Shen, Lian Bai, Chao-Ling Wan, De-Pei Wu, Jin-Li Li, Shengli Xue
There have been few reports on the treatment of central nervous system (CNS) acute myeloid leukemia (AML) relapse. This case study demonstrates that bevacizumab may be a viable treatment option when combined with IT chemotherapy as maintenance therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb02ab20ec9ff2d6138948eee50e3c0b
https://doi.org/10.22541/au.164027717.72466583/v1
https://doi.org/10.22541/au.164027717.72466583/v1
